Gedocarnil
Alternative Names: SH 530; ZK 113315Latest Information Update: 17 Jul 1996
At a glance
- Originator Bayer Schering Pharma
- Class Anxiolytics; Neuroprotectants; Nootropics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cognition disorders
Most Recent Events
- 12 Jun 1995 Discontinued-I for Cognition disorders in Germany (Unknown route)